Cytokinetics Inc (CYTK)
Payables turnover
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Cost of revenue | US$ in thousands | 339,408 | 330,123 | 240,813 | 159,938 | 96,951 |
| Payables | US$ in thousands | — | — | — | — | — |
| Payables turnover | — | — | — | — | — |
December 31, 2024 calculation
Payables turnover = Cost of revenue ÷ Payables
= $339,408K ÷ $—K
= —
The payables turnover ratio for Cytokinetics Inc for the years 2020 to 2024 is not available in the data provided. The payables turnover ratio is a financial metric that measures how efficiently a company is managing its accounts payable by comparing the cost of goods sold to the average accounts payable balance.
A high payables turnover ratio indicates that the company is paying off its suppliers quickly, which can be beneficial in terms of maintaining good relationships and potentially negotiating better terms in the future. On the other hand, a low payables turnover ratio may suggest that the company is taking longer to pay its suppliers, which could indicate potential liquidity issues or inefficiencies in cash management.
Without the specific values for Cytokinetics Inc's payables turnover ratio, it is not possible to provide a detailed analysis of how the company is managing its accounts payable over the years in question.
Peer comparison
Dec 31, 2024